Senior insider sale
Chief Executive Officer at PYXIS ONCOLOGY, INC. — senior position signals high conviction
$45.4K
20K shares
What this filing means
SULLIVAN LARA plans to sell 20K shares of PYXIS ONCOLOGY, INC. valued at approximately $45.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2023ACC: 0001959173-23-003883
DirectorOfficer· Chief Executive Officer
Since Oct 2021
20K
Shares to sell
$45.4K
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/31/2023
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2023 | Restricted Stock Vesting Compensation | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$45.4K
9/11/2023
Total
Units
20K
Value
$45.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/11/2023 | 20K | $45.4K | NASDAQ | Planned |
| Total | 20K | $45.4K | ||